侵襲性肺アスペルギロシスの新たな危険因子: 記述的レビュー
Ahmed Elkhapery1, Mariam Fatima2, Ayman O Soubani3
1Department of Medicine, Rochester General Hospital, Rochester, NY 14621, USA.
Journal of fungi (Basel, Switzerland)
|August 27, 2025
まとめ
侵襲性肺アスペルギロシス (IPA) は,免疫不全の患者で増加しています. 早期発見とスクリーニングのプロトコルは これらの新興リスクグループでの結果を改善するために不可欠です.
科学分野:
- 菌類学
- 感染症
- 肺科
背景:
- アスペルギルスの種は 免疫状態に影響される様々な病気を引き起こします
- 侵襲性肺アスペルギロシス (IPA) は,伝統的に免疫力が低下した個人に影響します.
- IPAの新たな危険因子には,ウイルス感染,COPD,肝不全,重症性疾患が含まれます.
研究 の 目的:
- IPAの病理生理学,発生率,およびリスク因子を新興リスク因子を持つ患者で検討する.
- これらの新たに認められた患者グループにおけるIPAの診断と治療の検討について議論する.
- 早期診断とスクリーニングの重要性を強調し,患者の治療結果を改善する.
主な方法:
- IPAに関する最近の研究の文献レビュー.
- 新興リスク要因と臨床表現の分析
- 診断と治療戦略の統合
主要な成果:
- IPAは,古典的な免疫不全のない患者でますます認識されています.
- 診断が遅れた場合,罹患患者の死亡率が著しく増加します.
- 定期的なスクリーニングと高い疑い指数は 早期診断に不可欠です
結論:
- IPAは重度の免疫不全以外にも新たな危険因子を持っています.
- 積極的な診断とスクリーニングのアプローチは,多様な患者集団におけるIPAの管理に不可欠です.
- 認知と管理の改善は IPAに関連する死亡率を減らすことができます.
さらに関連する動画
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
10.7K
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
3.5K
関連する概念動画
COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Pneumonia I: Introduction
1.5K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia II: Pathophysiology
4.7K
The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia III: Complications and Assessment
1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pneumothorax II: Pathophysiology
55
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance...
55
Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
